{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:42:52Z","timestamp":1772815372690,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2008,10,21]],"date-time":"2008-10-21T00:00:00Z","timestamp":1224547200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1007\/s00404-008-0806-1","type":"journal-article","created":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T08:00:14Z","timestamp":1224489614000},"page":"803-807","source":"Crossref","is-referenced-by-count":2,"title":["Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6\/11\/16\/18) vaccine"],"prefix":"10.1007","volume":"279","author":[{"given":"Elisabeth","family":"Barthell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linn","family":"Woelber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Hellner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birka","family":"Camerer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"Gieseking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maik","family":"Hauschild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioannis","family":"Mylonas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Friese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather L.","family":"Sings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha","family":"Railkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Gause","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliav","family":"Barr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,21]]},"reference":[{"key":"806_CR1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","volume":"87","author":"FX Bosch","year":"1995","unstructured":"Bosch FX, Manos MM, Mu\u00f1oz N et al (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst 87:796\u2013802. doi: 10.1093\/jnci\/87.11.796","journal-title":"J Natl Cancer Inst"},{"key":"806_CR2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ijc.2910250509","volume":"25","author":"L Gissmann","year":"1980","unstructured":"Gissmann L, zur Hausen H (1980) Partial characterization of viral DNA from human genital warts (condylomata acuminata). Int J Cancer 25:605\u2013609. doi: 10.1002\/ijc.2910250509","journal-title":"Int J Cancer"},{"key":"806_CR3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/S0030-6665(05)70270-X","volume":"33","author":"CS Derkay","year":"2000","unstructured":"Derkay CS, Darrow DH (2000) Recurrent respiratory papillomatosis of the larynx: current diagnosis and treatment. Otolaryngol Clin North Am 33:1127\u20131142. doi: 10.1016\/S0030-6665(05)70270-X","journal-title":"Otolaryngol Clin North Am"},{"key":"806_CR4","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1001\/jama.298.7.743","volume":"298","author":"A Hildesheim","year":"2007","unstructured":"Hildesheim A, Herrero R, Wacholder S et al (2007) Effect of human papillomavirus 16\/18 L1 virus like particle vaccine among young women with preexisting infection: a randomized trial. JAMA 298:743\u2013753. doi: 10.1001\/jama.298.7.743","journal-title":"JAMA"},{"key":"806_CR5","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","volume":"356","author":"SM Garland","year":"2007","unstructured":"Garland SM, Hernandez-Avila M, Wheeler CM et al (2007) Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 356:1928\u20131943. doi: 10.1056\/NEJMoa061760","journal-title":"N Engl J Med"},{"key":"806_CR6","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1056\/NEJMoa061741","volume":"356","author":"FUTURE II Study Group","year":"2007","unstructured":"FUTURE II Study Group (2007) Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 356:1915\u20131927. doi: 10.1056\/NEJMoa061741","journal-title":"N Engl J Med"},{"key":"806_CR7","doi-asserted-by":"crossref","unstructured":"Delere Y, Meyer C, Reiter S (2007) Universal immunisation with human papillomavirus (HPV) vaccine among females aged 12\u201317 recommended in Germany. Euro Surveill 12:E0704052","DOI":"10.2807\/esw.12.14.03169-en"},{"key":"806_CR8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00006250-200609000-00047","volume":"108","author":"Committee on Adolescent Health Care, ACOG Working Group on Immunization","year":"2006","unstructured":"Committee on Adolescent Health Care, ACOG Working Group on Immunization (2006) ACOG Committee Opinion No. 344: Human papillomavirus vaccination. Obstet Gynecol 108:699\u2013705","journal-title":"Obstet Gynecol"},{"key":"806_CR9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1128\/CVI.00478-06","volume":"14","author":"SM Garland","year":"2007","unstructured":"Garland SM, Steben M, Hernandez-Avila M et al (2007) Noninferiority of antibody response to human papillomavirus type 16 in subjects vaccinated with monovalent and quadrivalent L1 virus-like particle vaccines. Clin Vaccine Immunol 14:792\u2013795. doi: 10.1128\/CVI.00478-06","journal-title":"Clin Vaccine Immunol"},{"key":"806_CR10","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1542\/peds.2006-0461","volume":"118","author":"SL Block","year":"2006","unstructured":"Block SL, Nolan T, Sattler C et al (2006) Comparison of the immunogenicity and reactogenicity of a prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in male and female adolescents and young adult women. Pediatrics 118:2135\u20132145. doi: 10.1542\/peds.2006-0461","journal-title":"Pediatrics"},{"key":"806_CR11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jmv.20512","volume":"78","author":"J Bryan","year":"2006","unstructured":"Bryan J, Taddeo F, Skulsky D et al (2006) Detection of specific human papillomavirus types in paraffin-embedded sections of cervical carcinomas. J Med Virol 78:117\u2013124. doi: 10.1002\/jmv.20512","journal-title":"J Med Virol"},{"key":"806_CR12","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.287.16.2114","volume":"287","author":"D Solomon","year":"2002","unstructured":"Solomon D, Davey D, Kurman R et al (2002) The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA 287:2114\u20132119. doi: 10.1001\/jama.287.16.2114","journal-title":"JAMA"},{"key":"806_CR13","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1128\/CDLI.12.8.959-969.2005","volume":"12","author":"D Dias","year":"2005","unstructured":"Dias D, Van Doren J, Schlottmann S et al (2005) Optimization and validation of a multiplexed luminex assay to quantify antibodies to neutralizing epitopes on human papillomavirus 6, 11, 16 and 18. Clin Diag Lab Immunol 12:959\u2013969. doi: 10.1128\/CDLI.12.8.959-969.2005","journal-title":"Clin Diag Lab Immunol"},{"key":"806_CR14","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1185\/03007990802068151","volume":"24","author":"J Paavonen","year":"2008","unstructured":"Paavonen J (2008) Baseline demographic characteristics of subjects enrolled in international quadrivalent HPV (types 6\/11\/16\/18) vaccine clinical trials. Curr Med Res Opin 24:1623\u20131634. doi: 10.1185\/03007990802068151","journal-title":"Curr Med Res Opin"},{"key":"806_CR15","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0090-8258(92)90008-7","volume":"44","author":"EM Villiers de","year":"1992","unstructured":"de Villiers EM, Wagner D, Schnieder A et al (1992) Human papillomavirus DNA in women without and with cytological abnormalities: results of a 5-year follow-up study. Gynecol Oncol 44:33\u201339. doi: 10.1016\/0090-8258(92)90008-7","journal-title":"Gynecol Oncol"},{"key":"806_CR16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G","volume":"89","author":"A Schneider","year":"2000","unstructured":"Schneider A, Hoyer H, Lotz B et al (2000) Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 89:529\u2013534. doi:10.1002\/1097-0215(20001120)89:6<529::AID-IJC11>3.0.CO;2-G","journal-title":"Int J Cancer"},{"key":"806_CR17","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","volume":"369","author":"J Paavonen","year":"2007","unstructured":"Paavonen J, Jenkins D, Bosch FX et al (2007) Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial. Lancet 369:2161\u20132170. doi: 10.1016\/S0140-6736(07)60946-5","journal-title":"Lancet"},{"key":"806_CR18","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1007\/PL00011271","volume":"20","author":"A Clad","year":"2001","unstructured":"Clad A, Prillwitz J, Hintz KC et al (2001) Discordant prevalence of Chlamydia trachomatis in asymptomatic couples screened using urine ligase chain reaction. Eur J Clin Microbiol Infect Dis 20:324\u2013328","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"806_CR19","first-page":"1","volume":"2","author":"J Koch","year":"1997","unstructured":"Koch J, Kirschner W, Schaefer A (1997) Bestimmung der Praevalenz genitaler HPV- und Chlamydia trachomatis-Infektionen in einem repraesentativen Querschnitt der weiblichen Normalbevoelkerung in Berlin. Infektionsepidemiol Forsch 2:1\u20137","journal-title":"Infektionsepidemiol Forsch"},{"key":"806_CR20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1469-0691.2006.01680.x","volume":"13","author":"G Griesinger","year":"2007","unstructured":"Griesinger G, Gille G, Klapp C et al (2007) Sexual behaviour and Chlamydia trachomatis infections in German female urban adolescents, 2004. Clin Microbiol Infect 13:436\u2013439. doi: 10.1111\/j.1469-0691.2006.01680.x","journal-title":"Clin Microbiol Infect"},{"key":"806_CR21","unstructured":"Robert-Koch-Institut EU bordernet surveillance on HIV\/STD. http:\/\/www.rki de\/cln_049\/nn_196664\/DE\/Content\/InfAZ\/S\/STD\/Studien\/Bordernet\/Bordernet_inhalt html#doc207858bodyText3 , 2007"},{"key":"806_CR22","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ijc.22325","volume":"120","author":"MM Madeleine","year":"2007","unstructured":"Madeleine MM, Anttila T, Schwartz SM et al (2007) Risk of cervical cancer associated with Chlamydia trachomatis antibodies by histology, HPV type and HPV cofactors. Int J Cancer 120:650\u2013655. doi: 10.1002\/ijc.22325","journal-title":"Int J Cancer"},{"key":"806_CR23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/01.olq.0000258417.66619.0e","volume":"34","author":"S Franceschi","year":"2007","unstructured":"Franceschi S, Smith JS, van den BA et al (2007) Cervical infection with Chlamydia trachomatis and Neisseria gonorrhoeae in women from ten areas in four continents. A cross-sectional study. Sex Transm Dis 34:563\u2013569","journal-title":"Sex Transm Dis"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-008-0806-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-008-0806-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-008-0806-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T12:43:12Z","timestamp":1589028192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-008-0806-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,21]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["806"],"URL":"https:\/\/doi.org\/10.1007\/s00404-008-0806-1","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,21]]}}}